▲全球視野 本土思考
中國的此類試驗數量猛增了七倍，達到135次。
中國已保證推進在線診斷和治療的發展。
惠譽資詢的一份報告顯示，為緩解當前的痛點並為未來的流行做好準備，預計中國醫療保健系統的數位化將迅速發展。
惠譽指出，電子記錄，數字處方和其他IT基礎設施將系統地跟蹤和分析大量患者數據，而AI和大數據將最終幫助醫院重新分配稀缺資源並提高診斷準確性。
當局還承諾促進在線診斷和治療以及基於網際網路的醫院的發展，這有望緩解線下醫療機構的壓力，並有助於預防和控制疫情。
預計中國將繼續受益於創新製藥行業的大量投資。
報告稱：「儘管中國藥品市場在藥品定價和智慧財產權保護水平較低的挑戰下仍面臨不確定性，但我們仍認為中國市場是亞太地區最具吸引力的投資目的地之一」。
預計中國的醫療保健系統將實現更大程度的技術整合，這將有助於解決該國醫療資源地理分布不均的問題。
該報告指出，與地方社區醫療保健中心相比，中國的醫生繼續集中在省會城市–限制了農村地區的醫療保健獲取。
惠譽補充道：「此外，中國的醫療體系還為醫生短缺而努力，工資低廉，缺乏當地診所和全科醫生也加劇了這一狀況。在中國，每千人只有1.5名醫生，而美國每千人只有2.5名醫生」。
這場大流行還推動了中國醫療保健行業的數位化轉型和創新。該行業已採用了新一代數位技術，包括雲計算，大數據和人工智慧。
2019年，中國醫藥市場價值估計為149.7b美元（CNY1.03t），比上年增長5.5％。到2020年，市場預計將增長3.2％至$ 149.37b（CNY1.07t）。＊
China's healthcare digitalisation to rapidly advance: Fitch
Authorities have pledged to advance the development of online diagnosis and treatment.
To relieve current pain points and prepare for future epidemics, the digitalisation of China's healthcare system is expected to rapidly advance, according to a report from Fitch Solutions.
Electronic records, digital prescriptions and other IT infrastructure will systematically track and analyse extensive patient data, whilst AI and big data will eventually help hospitals reallocate scarce resources and improve diagnosis accuracy, Fitch noted.
The authorities have also pledged to advance the development of online diagnosis and treatment as well as internet-based hospitals, which is expected to help ease the pressure on medical institutions offline and contribute to outbreak prevention and control.
China is expected to continue benefitting from significant investment from the innovative pharma industry.
"Whilst the Chinese pharmaceutical market continues to face uncertainty on the back of challenges around drug pricing and the low levels of intellectual property protection, we maintain our view that it presents one of the most attractive investment destinations in the Asia Pacific region," the report stated.
China’s healthcare system is also expected to see a greater integration of technology, which can help address the uneven geographic distribution of medical resources in the country.
The report noted that doctors in China continue to be concentrated in provincial capitals as compared to local level community healthcare centres – limiting healthcare access in the rural regions.
"Moreover, China’s healthcare system also grapples with a shortage of doctors, exacerbated by low wages and a lack of local clinics and general practitioners. In the country, there are only 1.5 doctors for every 1,000 people, compared with 2.5 for every 1,000 in the US," Fitch added.
The pandemic has also prompted the digital transformation and innovation in China's healthcare industry. The industry has adopted a new generation of digital technologies, including cloud computing, big data and artificial intelligence.
In 2019, China's pharmaceutical market is estimated to be valued at $149.7b (CNY1.03t), climbing 5.5% from the previous year. In 2020, the market is projected to grow 3.2% to $149.37b (CNY1.07t).